CRISPR_SCD001 / University of California - LARVOL DELTA

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease (clinicaltrials.gov) - P1/2 | N=9 | Not yet recruiting | Sponsor: Mark Walters, MD | Trial completion date: Jun 2028 ➔ Mar 2029 | Trial primary completion date: Jun 2025 ➔ Mar 2027 | Not yet recruiting ➔ Recruiting

Enrollment open • Trial completion date • Trial primary completion date • Genetic Disorders • Hematological Disorders • Sickle Cell Disease • Transplantation

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease (clinicaltrials.gov) - P1/2 | N=9 | Not yet recruiting | Sponsor: Mark Walters, MD | Trial completion date: Dec 2027 ➔ Jun 2028 | Trial primary completion date: Dec 2024 ➔ Jun 2025

Trial completion date • Trial primary completion date • Genetic Disorders • Hematological Disorders • Sickle Cell Disease • Transplantation • HP

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease (clinicaltrials.gov) - P1/2 | N=9 | Not yet recruiting | Sponsor: Mark Walters, MD | Trial completion date: Dec 2026 ➔ Dec 2027 | Trial primary completion date: Dec 2023 ➔ Dec 2024

Trial completion date • Trial primary completion date • Genetic Disorders • Hematological Disorders • Sickle Cell Disease • Transplantation • HP